Orexo's lead product ZUBSOLV® added to NY State Medicaid MAT Preferred Drug List

/PRNewswire/ -- Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), announced today information about improved market access position for ZUBSOLV® (buprenorphine and...

Related Keywords

New York ,United States ,Sweden ,Stockholm ,Uppsala ,Uppsala Lan ,Kentucky ,American ,Lena Wange ,Nikolaj Sorensen ,Ir Communications ,York Department Of Health ,Youtube ,Linkedin ,New York Department ,Nasdaq Stockholm Mid Cap ,Orexo ,